LI faces headwinds from domestic competition and nascent global sales in H2'26, with FY2025/FY2026 likely to be trough years before potentially recovering from FY2027 onwards. This is worsened by the aggressive discounting and the consequently impacted top/bottom lines, albeit with the ongoing cash burn mitigated by the rich balance sheet. LI's refreshed L series at higher ASPs already report robust order books, with it offering a promising potential for H2'26 recovery, pending further capacity ramp-up.









